Development and validation of RP-HPLC method for simultaneous determination of pyridoxine hydrochloride, isoniazid, pyrazinamide and rifampicin in pharmaceutical formulation

Chemia Analityczna

Volumn 54, Issue 6, 2009, Pages 1487-1499

  Dhal, S K ^a   Sharma, R ^a  

^a DEVI AHILYA UNIVERSITY   (India)

Author keywords

Isoniazid; Pyrazinamide; Pyridoxine hydrochloride; Reversed phase high performance liquid chromatography; Rifampicin; Validation

Indexed keywords

EID: 77952215955     PISSN: 00092223     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. The Merck Index, 13th ed. Merck and Co. Inc.: White House Station, NJ, 2001, p. 928, 1429,1474, 8046.
2. Martindale-The Complete Drug Reference, 33rd edn, edited by Sweetman, S .C., London: Pharmaceutical Press. 2002, p. 1386-1387, 215.
3. Indian Pharmacopoeia, The Controller of Publications, Delhi, 1996, p. 408-409.
4. British Pharmacopoeia, Her Majesty's Stationery Office, London, 2002, p. 1465-1466,1463.
5. United States Pharmacopoeia, 23rd edn, United States Pharmacopoeial Convention, Rockville, 1995. p. 1869-1871, 1596-1597, 1917.
6. Galai S.M., Blaih S.M. and Abdel-Hamid M.E, Anal. Lett., 25, 725 (1992).
7. Mariappan T.T., Jindal K.C. and Singh S., J. Pharm. Biomed. Anal, 36, 905-908 (2004).
8. Hassan H. Y. Mohamed A.M.I. and Mohamed F.A., Anal. Lett., 23, 617 (1990).
9. EI-Brashy A.M. and El-Hussein L. A., Anal. Lett., 30, 609-622 (1997).
10. Mohan B., Sharada N. and Singh S., J. Pharm. Biomed. Anal, 21, 429-437 (1999).
11. Nagaraja P., Murthy K., Srinivasa C. and Yathirajan H.S., Talanta, 43, 1075-1080(1996).
12. Mahfouz N.M. and Emara K.M, Talanta, 40, 1023-1029 (1993).
13. Lapa R AS. Lima J.L.F.C. and Santos J.L.M., Anal. Chim. Acta, 419, 17-23 (2002).
14. Mariappan T.T. Kumar V. Vijaya P., Bhutani H. and Singh S., Indian Drugs, 43(2), 106-111 (2006).
15. Ait Moussa L., Khassouani C.E., Soulaymani R., Jana M., Cassanas G., Alric R. and Hue B., J. Chromatogr. B, 766, 181-187 (2001).
16. Panchagnula R., Sood A., Sarda N., Kaur K. and Kaul C.L., J. Pharm. Biomed. Anal., 18, 1013-1020(1999).
17. Calleja I., Blanco-Prieto M.J., Ruz N., Renedo M.J. and Dios-Vieitez M.C.J. Chromatogr., 1031, 289-294 (2004).
18. Von Sassen W., Castro-Parra M., Musch E. and Eichelbaum M., J. Chromatogr., 338, 113-122 (1985).
19. Shah Y. Khanna S. Jindal K. and Dighe V.S., Drug Dev. Ind. Pharm, 18, 1589-1596 (1992).
20. Mahalanabis K.K., Basu D. and Roy B., Analyst, 114, 1311-1314 (1989).
21. Sharma C.S., Das S. and Talwar S.K., J. Assoc. Off. Anal. Chem., 70, 679-681 (1987).
22. Kakde R.B., Kasture A.V. and Wadodkar S.G., Indian J. Pharm. Sci., 64(1), 24-27(2002).
23. Benetton S A. Kedor- Hackmann E.R.M., Santoro M.I.R.M. and Borges V.M., Talanta, 47, 639-643 (1998).
24. Jain H.K., Gupta R. and Agrawal R.K., Indian Drugs, 41 (3), 153-155 (2004).
25. Torres-Sequeiros R.A., Garcia-Falcon M.S. and Simal-Gandara J., Chromatographia Suppl, 53, 236-239(2001).
26. Arayne M.S., Sultana N., Siddiqui FA., Zuberi M.H. and Mirza A.Z., Pak. J. Pharm. Sci., 20 (2), 149-156(2007).
27. Elsayed M.A., Belal S.F., Elwahly A.M. and Abdine H., J. Pharm Sci., 68 (6), 739-741 (1979).
28. Pathak A. and Rajput S.J, Indian J.Pharm Sci, 70 (4), 513-517 (2008).
29. Argekar AP, Kunjir S S. and Purandare K.S, J. Pharm. Biomed. Anal, 14,.1645-1650(1996).
30. Calleri E., De Lorenzi E., Furlanetto S., Massolini G. and Caccialanza .G., J. Pharm. Biomed. Anal, 29, 1089-1096 (2002).
31. Khuhawar M. Y. and Rind F.M.A, J. Chromatogr. B, 766, 357-363 (2002).
32. Goicoechea H.C. and Olivieri A.C., J. Pharm Biomed. Anal, 20, 681-686 (1999).
33. Espinosa-mansilla A., Acedo Valenzuela M.I, Munoz de la Peńa A, Salinas F. and Cańada Cańada F., Anal. Chim. Acta. 427, 129-136(2001).